Industry News
ANGLE achieves world first with FDA clearance for its Parsortix PC1 Clinical System
Parsortix liquid biopsy system cleared for use in metastatic breast cancer
Parsortix liquid biopsy system cleared for use in metastatic breast cancer
Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumor cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis
Researchers’ use of ParsortixTM System for studies into multiple cancers confirms the cell separation technology’s ability to harvest viable circulating tumor cells for a broad range of downstream analyses